High revision rates following repeat septic revision after failed one-stage exchange for periprosthetic joint infection in total knee arthroplasty.

Failed one-stage exchange arthroplasty Musculoskeletal Infection Outcomes Periprosthetic joint infection Periprosthetic joint infection (PJI) Repeat septic revision Revision total knee arthroplasty Survival antibiotics debridement infections knees organism(s) reoperation revision TKAs total knee arthroplasty (TKA)

Journal

The bone & joint journal
ISSN: 2049-4408
Titre abrégé: Bone Joint J
Pays: England
ID NLM: 101599229

Informations de publication

Date de publication:
Mar 2022
Historique:
entrez: 1 3 2022
pubmed: 2 3 2022
medline: 11 3 2022
Statut: ppublish

Résumé

The outcome of repeat septic revision after a failed one-stage exchange for periprosthetic joint infection (PJI) in total knee arthroplasty (TKA) remains unknown. The aim of this study was to report the infection-free and all-cause revision-free survival of repeat septic revision after a failed one-stage exchange, and to determine whether the Musculoskeletal Infection Society (MSIS) stage is associated with subsequent infection-related failure. We retrospectively reviewed all repeat septic revision TKAs which were undertaken after a failed one-stage exchange between 2004 and 2017. A total of 33 repeat septic revisions (29 one-stage and four two-stage) met the inclusion criteria. The mean follow-up from repeat septic revision was 68.2 months (8.0 months to 16.1 years). The proportion of patients who had a subsequent infection-related failure and all-cause revision was reported and Kaplan-Meier survival for these endpoints was determined. Patients were categorized according to the MSIS staging system, and the association with subsequent infection was analyzed. At the most recent follow-up, 17 repeat septic revisions (52%) had a subsequent infection-related failure and the five-year infection-free survival was 59% (95% confidence interval (CI) 39 to 74). A total of 19 underwent a subsequent all-cause revision (58%) and the five-year all-cause revision-free survival was 47% (95% CI 28 to 64). The most common indication for the first subsequent aseptic revision was loosening. The MSIS stage of the host status (p = 0.663) and limb status (p = 1.000) were not significantly associated with subsequent infection-related failure. Repeat septic revision after a failed one-stage exchange TKA for PJI is associated with a high rate of subsequent infection-related failure and all-cause revision. Patients should be counselled appropriately to manage expectations. The host and limb status according to the MSIS staging system were not associated with subsequent infection-related failure. Cite this article:

Identifiants

pubmed: 35227090
doi: 10.1302/0301-620X.104B3.BJJ-2021-0481.R2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

386-393

Auteurs

Michael E Neufeld (ME)

Department of Orthopaedic Surgery, Helios ENDO-Klinik Hamburg, Hamburg, Germany.
Department of Orthopaedics, Division of Lower Limb Reconstruction, University of British Columbia, Vancouver, Canada.

Emanuel F Liechti (EF)

Department of Orthopaedic Surgery, Helios ENDO-Klinik Hamburg, Hamburg, Germany.
Department of Orthopaedic Surgery and Traumatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Fernando Soto (F)

Department of Orthopaedic Surgery, Helios ENDO-Klinik Hamburg, Hamburg, Germany.
Department of Orthopaedic Surgery, Hospital Naval Almirante Nef, Viña del Mar, Chile.

Philip Linke (P)

Department of Orthopaedic Surgery, Helios ENDO-Klinik Hamburg, Hamburg, Germany.

Sophia-Marlene Busch (SM)

Department of Orthopaedic Surgery, Helios ENDO-Klinik Hamburg, Hamburg, Germany.

Thorsten Gehrke (T)

Department of Orthopaedic Surgery, Helios ENDO-Klinik Hamburg, Hamburg, Germany.

Mustafa Citak (M)

Department of Orthopaedic Surgery, Helios ENDO-Klinik Hamburg, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH